Head-to-head comparison
Kova vs MEDGm
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Kova is a 50-state GLP-1 weight-loss program from LifeTech Apps Inc, a Delaware company, selling compounded semaglutide and tirzepatide — injectable or oral — with the medication included in the plan price and a companion app that tracks weight, protein intake and side effects.
$299/mo sema · $399/mo tirz · Verified August 2026
Marked down on: At $299 and $399 a month, the standing month-to-month rates are among the dearest compounded GLP-1 options we track — the low figures all require a three-, six- or twelve-month commitment paid or billed in full
Desk Score
MEDGm names four dispensing pharmacies with addresses and serves all 50 states, but its price only appears after a sixteen-screen intake, and the $179 it advertises lasts one month.
From $299/mo sema · From $399/mo tirz · Verified September 2026
Marked down on: No price appears until a sixteen-screen intake ends in a name, an email address and a phone number.
Kova takes this head-to-head with the higher Desk Score, 72/100 (C) against 63/100 (C) for MEDGm. MEDGm still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Kova
72/100
C
MEDGm
63/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Kova | MEDGm |
|---|---|---|
| Semaglutide | $299/mo$299/mo month-to-month ($249 for the first month); $179/mo on a 3-month plan ($537 up front); $149/mo on a 6-month plan ($894 up front); $129/mo on a 12-month plan ($1,548 up front); medication included; compounded | From $299/moFrom $299/mo (compounded) |
| Tirzepatide | $399/mo$399/mo month-to-month ($299 for the first month); $249/mo on a 3-month plan ($747 up front); $229/mo on a 6-month plan ($1,374 up front); $199/mo on a 12-month plan ($2,388 up front); medication included; compounded | From $399/moFrom $399/mo (compounded) |
| Coverage | All 50 states | All 50 states and D.C. |
| Brand-name | Compounded only | Compounded only |
| Oral option | Yes | Yes |
| Best for | People who want compounded semaglutide or tirzepatide with the medication included in one price, a published four-rung ladder for each, and a tracking app bundled in. | Anyone who will complete a long intake to see a price, and who prices month two rather than month one. |
| Desk Score | 72/100C | 63/100C |
The verdict
Desk pick — KovaKova takes this head-to-head with the higher Desk Score, 72/100 (C) against 63/100 (C) for MEDGm. MEDGm still holds its ground where its strengths line up with yours.
Choose Kova if…
People who want compounded semaglutide or tirzepatide with the medication included in one price, a published four-rung ladder for each, and a tracking app bundled in.
$299/mo sema · $399/mo tirz · All 50 states
Choose MEDGm if…
Anyone who will complete a long intake to see a price, and who prices month two rather than month one.
From $299/mo sema · From $399/mo tirz · All 50 states and D.C.
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Kova · MEDGm.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs Kova
- CoreAge Rx vs MEDGm
- Kova vs SkinnyRx
- Apex MD vs MEDGm
- Apex MD vs Kova
- MEDGm vs TeleCareSpot
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.